SCHEMBL5011069

SCHEMBL5011069

CC1CC(CC(=O)c2ccc(Br)cc2)(C(=O)O)CCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.36
AKR1B1 P15121 2/20 0.36
ALDH1A1 P00352 5/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
MPI P34949 1/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
HAO1 Q9UJM8 1/20 0.34
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5011043 0.84 MMP2 (0.34) AKR1B1MAPTHPGDL3MBTL1
SCHEMBL5009236 0.74 CYP2C19 (0.31) AKR1B1
SCHEMBL1747924 0.70 ALDH1A1 (0.43) GSK3BALDH1A1KMT2ALMNAMAPT
SCHEMBL5009223 0.69
SCHEMBL5006816 0.68 ALDH1A1 (0.41) GSK3BALDH1A1KMT2ALMNAMAPT
SCHEMBL1748001 0.65 OPRM1 (0.44) GSK3BALDH1A1KMT2ALMNAMAPT
SCHEMBL12265857 0.62 KMT2A (0.44) GSK3BALDH1A1KMT2ALMNAMAPT
SCHEMBL3392114 0.62 KMT2A (0.51) GSK3BALDH1A1KMT2ALMNAMAPT
SCHEMBL2635792 0.61 HAO1 (0.63) GSK3BALDH1A1KMT2AMAPTHDAC1
SCHEMBL22921696 0.60 AKR1B1 (0.40) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423156-B2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity BAYER PHARMACEUTICALS CORPORATION (US) 2008-09-09 US disclosed